AI: DeepSeek (deepseek-chat)

Q: {
  "guidelineId": "cg1127-neonatal-abstinence-scoring-pdf",
  "fieldsProcessed": [
    "humanFriendlyName",
    "organisation",
    "yearProduced",
    "summary"
  ],
  "enhancedFields": 4,
  "contentLength": 6543
}

A: {
  "success": true,
  "enhancedFields": [
    {
      "field": "humanFriendlyName",
      "oldValue": null,
      "newValue": "Neonatal Abstinence Syndrome Assessment and Management",
      "action": "added"
    },
    {
      "field": "organisation",
      "oldValue": null,
      "newValue": "The text does not explicitly mention a specific publishing organization or institution such as NHS, NICE, WHO, RCOG, etc. Therefore, I cannot identify the organization name from the provided guideline text",
      "action": "added"
    },
    {
      "field": "yearProduced",
      "oldValue": null,
      "newValue": "There is no publication year provided in the given text. Could you please provide the text that includes the publication year?",
      "action": "added"
    },
    {
      "field": "summary",
      "oldValue": null,
      "newValue": "**Summary of Neonatal Abstinence Syndrome (NAS) Guideline** **Scope**: Applies to pediatric, neonatal, and midwifery staff caring for newborns at risk of NAS due to maternal substance use. **Key Responsibilities**: - Staff must follow guidelines, use professional judgment, and ensure accessibility. - Monitor and manage NAS symptoms using standardized tools. **Common Substances & Effects**: - **Opiates**: Risk of premature birth, low birth weight; avoid pethidine/diamorphine in labor. - **Benzodiazepines**: Withdrawal symptoms may appear late (10 daysâ€“6 weeks). - **Alcohol**: Risk of fetal alcohol syndrome; phenobarbitone for withdrawal. - **Cocaine/Cannabis**: Placental abruption, irritability. - **Hepatitis B**: Vaccinate infants of high-risk mothers. **Management**: - **Antenatal**: Counsel parents, arrange neonatal unit visits if needed, refer to social services. - **Perinatal**: Avoid naloxone in opiate-dependent mothers. - **Postnatal**: Observe for withdrawal (minimum 2 days), use scoring charts, encourage breastfeeding where safe. **Pharmacological Treatment**: - **Opiate withdrawal**: Start morphine (125 mcg/kg/day), wean gradually based on NAS scores. - **Non-opiate withdrawal**: Phenobarbitone (alcohol), chlorpromazine (benzodiazepines). **Discharge Criteria**: Stable NAS scores, normal feeding/sleeping, no morphine changes for 36 hours. Ensure social support and follow-up. **Patient Education**: Provide information on NAS and monitoring reasons. **Audit**: Ensure compliance with antenatal plans, NAS scoring, and discharge protocols",
      "action": "added"
    }
  ]
}